bromocriptine has been researched along with Cardiomyopathies in 50 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (2.00) | 18.7374 |
| 1990's | 1 (2.00) | 18.2507 |
| 2000's | 9 (18.00) | 29.6817 |
| 2010's | 31 (62.00) | 24.3611 |
| 2020's | 8 (16.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chaparro, S; Hernandez, GA; Ibrahim, M; Kittipibul, V; Mahabir, S; Saint Croix, GR; Trongtorsak, A | 1 |
| Mujkanovic, J; Qayyum, AA | 1 |
| Adamo, L; Al'Aref, SJ; Asnani, A; Chidambaram, V; Kumar, A; Lau, ES; Majella, MG; Mehta, JL; Ravi, R; Sharma, G; Sinha, S; Sivakumar, RK | 1 |
| Bauersachs, J; Berliner, D; Erschow, S; Haebel, L; Hilfiker-Kleiner, D; Koenig, T; Mueller, JH; Pfeffer, TJ; Ricke-Hoch, M; Scherr, M; Talbot, SR; Yalman, KC; Zwadlo, C | 1 |
| Bauersachs, J; Berliner, D; König, T; Pfeffer, TJ | 1 |
| Abdullaev, TA; Kurbanov, RD; Mirzarakhimova, ST; Tsoy, IA | 1 |
| Demkow, M; Dzielinska, Z; Kryczka, KE | 1 |
| Akhyari, P; Hilfiker-Kleiner, D; Horn, P; Kelm, M; Saeed, D; Westenfeld, R | 1 |
| Arrigo, M; Blet, A; Mebazaa, A | 1 |
| Angermann, CE; Bauersachs, J; Berliner, D; Böhm, M; Ehlermann, P; Fischer, D; Franke, A; Haghikia, A; Hilfiker-Kleiner, D; Kindermann, I; Kühl, U; Michels, G; Pfister, R; Podewski, E; Schlitt, A; Schwab, J; Schwarzkopf, M; Sliwa, K; Stangl, V; Vogel-Claussen, J; Westenfeld, R | 1 |
| Coats, CJ; Dalzell, JR; Jackson, AM; Jhund, PS; Petrie, MC; Walker, NL | 1 |
| Bauersachs, J; Berliner, D; Hallbaum, M; Hilfiker-Kleiner, D; König, T; Kühn, C; Napp, LC; Pfeffer, TJ; Schäfer, A; Schmitto, JD; Sieweke, JT; Tongers, J | 1 |
| Bauersachs, J; Hilfiker-Kleiner, D; Sliwa, K | 2 |
| Arany, Z; Ersbøll, AS; Gustafsson, F | 1 |
| Bauersachs, J; Berliner, D; Böhm, M; Ehlermann, P; Franke, A; Haghikia, A; Hilfiker-Kleiner, D; Kindermann, I; König, T; Kühl, U; Michels, G; Moulig, VA; Pfeffer, T; Pfister, R; Podewski, E; Schwab, J; Schwarzkopf, M; Sliwa, K; Stangl, V; Vogel-Claussen, J; Westenfeld, R; Zwadlo, C | 1 |
| Fett, JD | 2 |
| Afilalo, J; Avram, R; Bélisle, P; Bibas, L; Couture, E; Descarries, L; Desplantie, O; Diaz, A; Ducharme, A; Farand, P; Fortier, A; Harvey, L; Jolicoeur, EM; Ly, HQ; Malhamé, I; Marquis-Gravel, G; Pacheco, C; Poulin, A; Pranno, N; Rey, E; Sénéchal, M; Simard, F; Tournoux, F; Tran, D; Tremblay-Gravel, M | 1 |
| A Kamiya, C; Eto, K; Fukui, D; Fukumoto, Y; Furusho, A; Kumanomido, J; Morikawa, N; Nakayoshi, T; Nishida, N; Nishihara, M; Watanabe, M; Yoshimura, H | 1 |
| Bauersachs, J; Bovy, N; Fischer, D; Haghikia, A; Hilfiker-Kleiner, D; Jordan, J; Labidi, S; Libhaber, E; Lichtinghagen, R; Podewski, E; Roentgen, P; Sliwa, K; Struman, I; Tsikas, D; von Kaisenberg, CS | 1 |
| Hamada, T; Idei, M; Sumikura, H | 1 |
| Angermann, CE; Bauersachs, J; Berliner, D; Böhm, M; Fischer, D; Haghikia, A; Hilfiker-Kleiner, D; Podewski, E; Röntgen, P; Sonnenschein, K | 1 |
| Avram, R; Desplantie, O; Ducharme, A; Jolicoeur, EM; Marquis-Gravel, G; Tremblay-Gravel, M | 1 |
| Cardona-Guarache, R; Kron, J | 1 |
| Lough, S | 1 |
| Bouabdallaoui, N; Demondion, P; Ennezat, PV; Le Jemtel, TH; Lebreton, G; Mouquet, F | 1 |
| Arany, Z; Elkayam, U | 1 |
| Nicholls, M | 1 |
| Dietz, R; Dudenhausen, JW; Elgeti, T; Habedank, D; Haverkamp, W; Kühnle, Y | 1 |
| Emons, G; Hilfiker-Kleiner, D; Jahns, BG; Pieske, B; Stein, W | 1 |
| Bretler, DM; Gislason, GH; Hansen, PR; Jørgensen, CH; Olesen, JB | 1 |
| de Groote, P; Lamblin, N; Mouquet, F | 1 |
| Biteker, M; Duran, NE; Ozkan, M | 1 |
| Swalve-Bordeaux, S | 1 |
| Becker, A; Blauwet, L; Hilfiker-Kleiner, D; Labidi, S; Libhaber, E; McMurray, J; Sliwa, K; Smedema, JP; Struhman, I; Struman, I; Tibazarwa, K; Yamac, H | 1 |
| Elkayam, U; Goland, S | 1 |
| Bultmann, I; Hilfiker-Kleiner, D; Sliwa, K; Yamac, H | 1 |
| Abe, T; Akira, S; Amano, I; Nakai, A; Sawa, R; Takeshita, T | 1 |
| Schröder, S; Strobel, J | 1 |
| Czerski, T; Piotrowska-Kownacka, D | 1 |
| Böhm, M; Friedrich, EB; Hilfiker-Kleiner, D; Kindermann, I; Labidi, S; Schirmer, SH; Schwarz, V; Sliwa, K; Solomayer, EF; Walenta, K | 1 |
| Arany, Z; Bauersachs, J; Burke, SD; del Monte, F; Farrell, C; Hacker, MR; Hess, P; Hilfiker-Kleiner, D; Jang, C; Karumanchi, SA; Khankin, EV; Koulisis, N; Liu, L; Mahmood, F; Mitchell, J; Patten, IS; Rana, S; Rhee, JS; Rowe, GC; Shahul, S; Tudorache, I | 1 |
| Berardini, A; Biagini, E; Graziosi, M; Pazzi, C; Rapezzi, C; Rosmini, S | 1 |
| Hilfiker-Kleiner, D; Hoch, M; Podewski, E; Sliwa, K; Struman, I | 1 |
| Holke, K; Schillinger, W; Schroeter, MR; Unsöld, B | 1 |
| Leinwand, LA | 1 |
| Ansari, A; Balligand, JL; Bonda, T; Desjardins, F; Doerries, C; Drexler, H; Forster, O; Heusch, G; Hilfiker, A; Hilfiker-Kleiner, D; Kaminski, K; Klein, G; Landmesser, U; Luchtefeld, M; Nguyen, NQ; Podewski, E; Poli, V; Quint, A; Schaefer, A; Schneider, MD; Schulz, R; Sliwa, K; Struman, I; Zschemisch, NH | 1 |
| Bertoni, PD; Canziani, R; Di Michele, R; Morandi, G | 1 |
| Correia, J; Hopp, L; Iffy, L; O'Donnell, J | 1 |
9 review(s) available for bromocriptine and Cardiomyopathies
| Article | Year |
|---|---|
Effects of bromocriptine in peripartum cardiomyopathy: a systematic review and meta-analysis.
Topics: Bromocriptine; Cardiomyopathies; Female; Heart Failure; Humans; Peripartum Period; Pregnancy; Pregnancy Complications, Cardiovascular; Randomized Controlled Trials as Topic; Stroke Volume; Ventricular Function, Left | 2022 |
Prolactin Inhibition in Peripartum Cardiomyopathy: Systematic Review and Meta-analysis.
Topics: Bromocriptine; Cardiomyopathies; Female; Heart Failure; Humans; Peripartum Period; Pregnancy; Pregnancy Complications, Cardiovascular; Prolactin; Stroke Volume; Ventricular Function, Left | 2023 |
Peripartum cardiomyopathy - a cardiovascular disease in pregnancy and puerperium. The actual state of knowledge, challenges, and perspectives.
Topics: Adult; Bacterial Outer Membrane Proteins; Bromocriptine; Cardiomyopathies; Cardiotonic Agents; Female; Health Knowledge, Attitudes, Practice; Heart Failure; Humans; Peripartum Period; Pregnancy; Pregnancy Complications, Cardiovascular; Puerperal Disorders; Treatment Outcome | 2021 |
[Anesthetic management of parturients with peripartum cardiomyopathy].
Topics: Analgesia, Obstetrical; Anesthesia, Epidural; Anesthesia, General; Anesthesia, Obstetrical; Anesthesia, Spinal; Anesthetics, Local; Animals; Bromocriptine; Cardiomyopathies; Cesarean Section; Female; Heart Transplantation; Humans; Monitoring, Intraoperative; Mutation; Oxidative Stress; Perioperative Care; Pregnancy; Pregnancy Complications, Cardiovascular; Prolactin | 2014 |
The Medical Treatment of New-Onset Peripartum Cardiomyopathy: A Systematic Review of Prospective Studies.
Topics: Bromocriptine; Cardiomyopathies; Echocardiography; Female; Humans; Hydrazones; Pentoxifylline; Pregnancy; Pregnancy Complications, Cardiovascular; Prospective Studies; Puerperal Disorders; Pyridazines; Randomized Controlled Trials as Topic; Simendan; Survival Rate; Ventricular Dysfunction, Left | 2015 |
Current knowledge and recent development on management of peripartum cardiomyopathy.
Topics: Bromocriptine; Cardiomyopathies; Echocardiography; Electrocardiography; Female; Heart Failure; Heart Transplantation; Heart-Assist Devices; Hormone Antagonists; Humans; Incidence; Natriuretic Peptide, Brain; Oxidative Stress; Peripartum Period; Pregnancy; Pregnancy Complications, Cardiovascular; Prolactin; Radiography, Thoracic; Ventricular Dysfunction, Left | 2017 |
Peripartum Cardiomyopathy.
Topics: Bromocriptine; Cardiomyopathies; Cardiovascular Agents; Disease Susceptibility; Female; Heart Failure; Heart Transplantation; Hormones; Humans; Hypertension; Incidence; Infant, Newborn; Lactation; Pre-Eclampsia; Pregnancy; Pregnancy Complications, Cardiovascular; Pregnancy, Multiple; Puerperal Disorders | 2016 |
Prolactin: a new therapeutic target in peripartum cardiomyopathy.
Topics: Animals; Bromocriptine; Cardiomyopathies; Disease Models, Animal; Female; Hormone Antagonists; Humans; Mice; Oxidative Stress; Pregnancy; Pregnancy Complications, Cardiovascular; Prolactin; Puerperal Disorders | 2010 |
16-kDa prolactin and bromocriptine in postpartum cardiomyopathy.
Topics: Bromocriptine; Cardiomyopathies; Female; Hormone Antagonists; Humans; Oxidative Stress; Peptide Fragments; Pregnancy; Pregnancy Complications, Cardiovascular; Prolactin; Puerperal Disorders | 2012 |
5 trial(s) available for bromocriptine and Cardiomyopathies
| Article | Year |
|---|---|
Bromocriptine for the treatment of peripartum cardiomyopathy: a multicentre randomized study.
Topics: Adult; Bromocriptine; Cardiomyopathies; Cardiotonic Agents; Drug Administration Schedule; Female; Humans; Pregnancy; Pregnancy Complications, Cardiovascular; Puerperal Disorders; Recovery of Function; Treatment Outcome; Ventricular Dysfunction, Left | 2017 |
Bromocriptine treatment in patients with peripartum cardiomyopathy and right ventricular dysfunction.
Topics: Bromocriptine; Cardiomyopathies; Dose-Response Relationship, Drug; Echocardiography; Female; Follow-Up Studies; Heart Ventricles; Hormone Antagonists; Humans; Magnetic Resonance Imaging, Cine; Peripartum Period; Pregnancy; Pregnancy Complications, Cardiovascular; Prospective Studies; Treatment Outcome; Ventricular Dysfunction, Right; Ventricular Function, Right | 2019 |
Rationale and design of a randomized, controlled multicentre clinical trial to evaluate the effect of bromocriptine on left ventricular function in women with peripartum cardiomyopathy.
Topics: Adult; Bromocriptine; Cardiomyopathies; Female; Humans; Multicenter Studies as Topic; Peripartum Period; Pregnancy; Pregnancy Complications, Cardiovascular; Randomized Controlled Trials as Topic; Research Design; Survival Rate; Treatment Outcome; Ventricular Dysfunction, Left; Young Adult | 2015 |
Evaluation of bromocriptine in the treatment of acute severe peripartum cardiomyopathy: a proof-of-concept pilot study.
Topics: Acute Disease; Adolescent; Adult; Blood Pressure; Bromocriptine; Cardiomyopathies; Cathepsin D; Female; Heart Failure; Hormone Antagonists; Humans; Infant, Newborn; Middle Aged; Parturition; Pilot Projects; Pregnancy; Pregnancy Complications, Cardiovascular; Pregnancy Outcome; Prolactin; Thromboembolism; Treatment Outcome; Ultrasonography; Ventricular Function, Left; Young Adult | 2010 |
A cathepsin D-cleaved 16 kDa form of prolactin mediates postpartum cardiomyopathy.
Topics: Animals; Bromocriptine; Cardiomyopathies; Cathepsin D; Disease Models, Animal; Female; Heart Transplantation; Humans; Hypertrophy, Left Ventricular; Lactation; Lipoproteins, LDL; Male; Mice; Mice, Knockout; Myocardium; Myocytes, Cardiac; Neovascularization, Pathologic; Oxidative Stress; Peptide Fragments; Postpartum Period; Pregnancy; Pregnancy Complications, Cardiovascular; Prolactin; Puerperal Disorders; STAT3 Transcription Factor | 2007 |
36 other study(ies) available for bromocriptine and Cardiomyopathies
| Article | Year |
|---|---|
Review of Randomized Controlled Trials in Patients with Peripartum Cardiomyopathy.
Topics: Bromocriptine; Cardiomyopathies; Cardiotonic Agents; Female; Heart Failure; Humans; Peripartum Period; Pregnancy; Pregnancy Complications, Cardiovascular; Prospective Studies; Randomized Controlled Trials as Topic; Stroke Volume; Ventricular Function, Left | 2023 |
Cabergoline treatment promotes myocardial recovery in peripartum cardiomyopathy.
Topics: Animals; Bromocriptine; Cabergoline; Cardiomyopathies; Dopamine Agonists; Female; Heart Failure; Mice; MicroRNAs; Myocytes, Cardiac; Peripartum Period; Pregnancy; Prolactin; Ventricular Dysfunction, Left | 2023 |
[Peripartum Cardiomyopathy].
Topics: Animals; Bromocriptine; Cardiomyopathies; Dopamine Agonists; Female; Heart Failure; Humans; Peripartum Period; Pregnancy; Pregnancy Complications, Cardiovascular; Prolactin; Puerperal Disorders; Shock, Cardiogenic; Ventricular Dysfunction, Left | 2022 |
[The Effect of Bromocriptine on Clinical and Laboratory Parameters in Patients With Peripartum Cardiomyopathy].
Topics: Bromocriptine; Cardiomyopathies; Humans; Peripartum Period; Quality of Life; Treatment Outcome | 2020 |
Complete recovery of fulminant peripartum cardiomyopathy on mechanical circulatory support combined with high-dose bromocriptine therapy.
Topics: Acute Disease; Adult; Bromocriptine; Cardiomyopathies; Dopamine Agonists; Dose-Response Relationship, Drug; Female; Heart-Assist Devices; Humans; Peripartum Period; Recovery of Function; Shock, Cardiogenic | 2017 |
Bromocriptine for the treatment of peripartum cardiomyopathy: welcome on BOARD.
Topics: Bromocriptine; Cardiomyopathies; Female; Humans; Peripartum Period; Puerperal Disorders | 2017 |
Peripartum cardiomyopathy: diagnosis and management.
Topics: Anticoagulants; Bromocriptine; Cardiac Resynchronization Therapy; Cardiomyopathies; Cardiotonic Agents; Contraception; Defibrillators; Delayed Diagnosis; Delivery, Obstetric; Drug Substitution; Female; Forecasting; Heart Transplantation; Heart-Assist Devices; Hormone Antagonists; Humans; Peripartum Period; Preconception Care; Pregnancy; Pregnancy Complications, Cardiovascular; Prenatal Diagnosis; Puerperal Disorders; Recovery of Function; Risk Factors; Treatment Outcome | 2018 |
Cardiogenic shock complicating peripartum cardiomyopathy: Importance of early left ventricular unloading and bromocriptine therapy.
Topics: Adult; Bromocriptine; Cardiomyopathies; Combined Modality Therapy; Extracorporeal Membrane Oxygenation; Female; Heart Failure; Hormone Antagonists; Humans; Peripartum Period; Pregnancy; Pregnancy Complications, Cardiovascular; Prospective Studies; Shock, Cardiogenic; Stroke Volume; Survival Rate; Treatment Outcome; Ventricular Function, Left | 2020 |
Reply to 'Bromocriptine for the treatment of peripartum cardiomyopathy: comparison of outcome with a nationwide Danish cohort'.
Topics: Bromocriptine; Cardiomyopathies; Denmark; Female; Humans; Peripartum Period; Puerperal Disorders | 2018 |
Bromocriptine for the treatment of peripartum cardiomyopathy: comparison of outcome with a Danish cohort.
Topics: Bromocriptine; Cardiomyopathies; Denmark; Female; Humans; Peripartum Period; Puerperal Disorders | 2018 |
More study still needed on the use of bromocriptine in the treatment of peripartum cardiomyopathy.
Topics: Bromocriptine; Cardiomyopathies; Female; Humans; Peripartum Period; Puerperal Disorders | 2018 |
Reply to 'More study still needed on the use of bromocriptine in the treatment of peripartum cardiomyopathy'.
Topics: Bromocriptine; Cardiomyopathies; Female; Humans; Peripartum Period; Puerperal Disorders | 2018 |
The effect of bromocriptine on left ventricular functional recovery in peripartum cardiomyopathy: insights from the BRO-HF retrospective cohort study.
Topics: Adult; Bromocriptine; Cardiomyopathies; Dopamine Agonists; Echocardiography; Female; Follow-Up Studies; Heart Ventricles; Humans; Peripartum Period; Pregnancy; Pregnancy Complications, Cardiovascular; Recovery of Function; Retrospective Studies; Stroke Volume; Treatment Outcome; Ventricular Function, Left | 2019 |
The Use of Bromocriptine for Peripartum Cardiomyopathy after Twin Delivery via Oocyte Donation.
Topics: Bromocriptine; Cardiomyopathies; Female; Humans; Middle Aged; Oocyte Donation; Peripartum Period; Pregnancy; Pregnancy Complications, Cardiovascular; Treatment Outcome; Ventricular Dysfunction, Left; Ventricular Function, Left | 2019 |
Phenotyping and outcome on contemporary management in a German cohort of patients with peripartum cardiomyopathy.
Topics: Adult; Antihypertensive Agents; Bromocriptine; Cardiomyopathies; Cohort Studies; Disease Management; Drug Therapy, Combination; Female; Follow-Up Studies; Germany; Humans; Oxidative Stress; Peripartum Period; Phenotype; Pregnancy; Prospective Studies; Registries; Stroke Volume; Treatment Outcome | 2013 |
Treatment of Peripartum Cardiomyopathy: A Call to Action.
Topics: Bromocriptine; Cardiomyopathies; Female; Humans; Hydrazones; Pentoxifylline; Pregnancy; Pregnancy Complications, Cardiovascular; Puerperal Disorders; Pyridazines | 2015 |
Resident-initiated research bucks tradition.
Topics: Biomedical Research; Bromocriptine; Canada; Cardiology; Cardiomyopathies; Financial Management; Humans; Internship and Residency; Needs Assessment; Pilot Projects; Research Support as Topic | 2015 |
An airport meeting that led to bromocriptine use in peripartum cardiomyopathy.
Topics: Airports; Animals; Bromocriptine; Cardiomyopathies; Female; Humans; Mice; Pregnancy; Pregnancy Complications, Cardiovascular; Puerperal Disorders | 2016 |
Recovery from peripartum cardiomyopathy after treatment with bromocriptine.
Topics: Adult; Bromocriptine; Cardiomyopathies; Female; Follow-Up Studies; Heart Failure; Hormone Antagonists; Humans; Infant, Newborn; Magnetic Resonance Imaging; Male; Postpartum Period; Pregnancy; Pregnancy Complications, Cardiovascular; Pregnancy Outcome; Recovery of Function | 2008 |
Peripartum cardiomyopathy--a new treatment option by inhibition of prolactin secretion.
Topics: Adult; Bromocriptine; Cardiomyopathies; Cathepsin D; Female; Heart Failure; HELLP Syndrome; Hormone Antagonists; Humans; Myocardium; Pregnancy; Pregnancy Complications, Cardiovascular; Prolactin | 2008 |
[Peripartum cardiomyopathy].
Topics: Bromocriptine; Cardiomyopathies; Female; Hormone Antagonists; Humans; Pregnancy; Pregnancy Complications, Cardiovascular; Puerperal Disorders; Risk Factors | 2009 |
Indication for bromocriptine in peripartum cardiomyopathy.
Topics: Bromocriptine; Cardiomyopathies; Female; Humans; Pregnancy; Pregnancy Complications, Cardiovascular | 2009 |
The role of bromocriptine in peripartum cardiomyopathy.
Topics: Bromocriptine; Cardiomyopathies; Female; Hormone Antagonists; Humans; Pregnancy; Pregnancy Complications, Cardiovascular | 2009 |
Correspondence (letter to the editor): Case numbers are tiny.
Topics: Bromocriptine; Cardiomyopathies; Female; Hormone Antagonists; Humans; Pregnancy; Pregnancy Complications, Cardiovascular | 2009 |
Bromocriptine for the treatment of peripartum cardiomyopathy.
Topics: Bromocriptine; Cardiomyopathies; Female; Hormone Antagonists; Humans; Pregnancy; Pregnancy Complications, Cardiovascular | 2010 |
Recovery from peripartum cardiomyopathy in a Japanese woman after administration of bromocriptine as a new treatment option.
Topics: Asian People; Bromocriptine; Cardiomyopathies; Dopamine Agonists; Female; Humans; Natriuretic Peptide, Brain; Pleural Effusion; Pregnancy; Pregnancy Complications, Cardiovascular; Pulmonary Edema; Radiography, Thoracic; Time Factors; Ultrasonography | 2010 |
[Postpartum cardiomyopathy].
Topics: Adrenergic beta-1 Receptor Antagonists; Adult; Angiotensin-Converting Enzyme Inhibitors; Anticoagulants; Antihypertensive Agents; Bisoprolol; Bromocriptine; Cardiomyopathies; Female; Heparin, Low-Molecular-Weight; Humans; Mineralocorticoid Receptor Antagonists; Postpartum Period; Radiography; Ramipril; Risk Factors; Spironolactone; Sulfonamides; Torsemide; Treatment Outcome | 2011 |
[Pulmonary oedema--as first symptom of the postpartum cardiomyopathy. The role of cardiac MRI in diagnostic process].
Topics: Bromocriptine; Cardiomyopathies; Cesarean Section; Diagnosis, Differential; Eclampsia; Female; Hormone Antagonists; Humans; Magnetic Resonance Imaging; Postpartum Period; Pregnancy; Pregnancy Complications, Cardiovascular; Pulmonary Edema; Radiography; Young Adult | 2011 |
Circulating microparticles as indicators of peripartum cardiomyopathy.
Topics: Adult; Analysis of Variance; Biomarkers; Bromocriptine; Cardiomyopathies; Case-Control Studies; Cell-Derived Microparticles; Female; Flow Cytometry; Hormone Antagonists; Humans; Pregnancy; Puerperal Disorders | 2012 |
Cardiac angiogenic imbalance leads to peripartum cardiomyopathy.
Topics: Animals; Bromocriptine; Cardiomyopathies; Disease Models, Animal; Female; Heart; Humans; Kaplan-Meier Estimate; Male; Mice; Mice, Knockout; Myocytes, Cardiac; Neovascularization, Pathologic; Neovascularization, Physiologic; Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha; Pre-Eclampsia; Pregnancy; Pregnancy Complications, Cardiovascular; Trans-Activators; Transcription Factors; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-1 | 2012 |
[Gender effect on cardiomyopathy].
Topics: Bromocriptine; Cabergoline; Cardiomyopathies; Cardiomyopathy, Dilated; Cardiomyopathy, Hypertrophic; Cardiomyopathy, Restrictive; Dopamine Agonists; Ergolines; Evidence-Based Medicine; Female; Genetic Counseling; Humans; Phenotype; Pregnancy; Pregnancy Complications, Cardiovascular; Prognosis; Prolactin; Risk Assessment; Risk Factors; Sex Factors; Treatment Outcome | 2012 |
Pro-thrombotic condition in a woman with peripartum cardiomyopathy treated with bromocriptine and an Impella LP 2.5 heart pump.
Topics: Adult; Anticoagulants; Blood Coagulation Tests; Bromocriptine; Cardiomyopathies; Dopamine Agonists; Echocardiography, Doppler, Color; Echocardiography, Transesophageal; Female; Heart-Assist Devices; Humans; Peripartum Period; Pregnancy; Puerperal Disorders; Thrombosis; Treatment Outcome; Ventricular Function, Left | 2013 |
Molecular events underlying pregnancy-induced cardiomyopathy.
Topics: Animals; Bromocriptine; Cardiomyopathies; Cathepsin D; Disease Models, Animal; Female; Humans; Pregnancy; Pregnancy Complications, Cardiovascular; Prolactin; Puerperal Disorders; STAT3 Transcription Factor | 2007 |
Caution in the use of bromocriptine in peripartum cardiomyopathy.
Topics: Bromocriptine; Cardiomyopathies; Developing Countries; Female; Heart Failure; Hormone Antagonists; Humans; Prolactin; Puerperal Disorders | 2008 |
[Acromegalic cardiomyopathy: an echocardiographic study].
Topics: Acromegaly; Adult; Aged; Bromocriptine; Cardiomyopathies; Echocardiography; Electrocardiography; Female; Humans; Hypophysectomy; Male; Middle Aged | 1983 |
Severe cardiac dysrhythmia in patients using bromocriptine postpartum.
Topics: Adult; Arrhythmias, Cardiac; Bromocriptine; Cardiomyopathies; Causality; Dopamine Agonists; Electrocardiography; Fatal Outcome; Female; Humans; Hypertension; Lactation; Long QT Syndrome; Pregnancy; Pregnancy Complications, Cardiovascular; Prolactin; Puerperal Disorders | 1998 |